Skip to main content
Download PDF

The pattern glare and visual memory are disrupted in patients with major depressive disorder

BMC Psychiatry volume 22, Article number: 518 (2022) Cite this article

Abstract

Background

Visual memory impairment is one of the most commonly complained symptoms in patients with major depressive disorder (MDD). Pattern glare is also a distorted visual phenomenon that puzzles patients with MDD. Nevertheless, how these two phenomena interact in MDD remains unknown. This study investigated the association between pattern glare and visual memory in MDD patients.

Methods

Sixty-two patients with MDD and forty-nine age-, sex- and education level-matched healthy controls (HCs) were included in this study. The Pattern Recognition Memory (PRM) test and the Brief Visual Memory Test-Revised (BVMT-R) were applied to measure visual memory. The pattern glare test including three patterns with different spatial frequencies (SFs) was used to explore pattern glare levels.

Results

Patients with MDD scored lower on the PRM-PCi, BVMT-R1, BVMT-R2, BVMT-R3, and BVMT-Rt and higher on the PRM-MCLd than HCs (all p < 0.05). Pattern glare scores for MDD patients were higher with mid-SF (p < 0.001), high-SF (p = 0.006) and mid-high SF differences (p = 0.01) than for HCs. A positive correlation between mid-SF and PRM-MCLd scores in all participants was observed (p = 0.01, r = 0.246). A negative correlation between mid-high difference scores and BVMT-R2 scores (p = 0.032, r = -0.317) was observed in HCs, but no significant correlation was observed in MDD patients.

Conclusions

The present study showed that visual memory and pattern glare are disrupted in MDD. Visual memory may be associated with pattern glare and needs to be studied in future work.

Peer Review reports

Background

Major depressive disorder (MDD) is a prevalent and complex syndrome not only characterized by depressed mood, diminished interests, and anhedonia but also accompanied by a wide range of abnormalities in cognition, sensation, and perception [1]. Cognitive impairment is recognized as one of the important symptoms of MDD and is included in the diagnostic criteria [2]. Patients with MDD have consistently demonstrated worse performance than healthy individuals on tests of memory, information processing speed, attention, and executive function [3]. Specifically, memory impairment is one of the most common cognitive impairments in patients with MDD.

Previous clinical studies have established that patients with acute depression show deficits in various memory domains, including but not limited to visual memory, visuospatial working memory, verbal memory, immediate memory, and delayed memory [4,5,6,7,8]. In addition, memory impairment not only affects function during acute episodes of the illness, as recent evidence suggests that cognitive dysfunction persists following symptomatic remission [9]. Recurrent MDD patients displayed residual memory dysfunction even after remission for three years, and persistent memory deficits may be a risk factor for the development of dementia [10]. Moreover, memory deficits during acute and remitted stages of MDD can contribute to symptoms of low mood and reduced occupational and social functioning that have clinical importance [11, 12]. These findings imply that memory dysfunction worsens emotional and social factors associated with MDD, highlighting the need to understand the mechanisms underlying these memory symptoms.

Pattern glare is visual perceptual distortions and / or physical discomforts such as headache, eyestrain, and illusions of color, shape, and motion when viewing repetitive striped patterns [13]. Pattern glare is usually assessed by square-wave gratings with even width and spacing, and high contrast [13]. Abnormal pattern glare has been revealed to be associated with migraine [14], stroke [15], and autism [16]. Some visual perception abnormalities, such as diminished perception of ambient light [17], photophobia [18], dysfunction of pre-attentive visual information processing [19], deficits in visual surround motion suppression [20], and reduced visual contrast suppression [21], have been observed by an abundance of studies in MDD patients. Our previous study indicates that MDD patients have elevated pattern glare [22].

Pattern glare shares some neural mechanisms with visual memory impairment. Pattern-provoked visual distortions and discomfort have been found to be associated with visual cortical hyperactivation caused by a stressful striped pattern [14, 23]. Further evidence indicates that visual cortical functional connectivity is indicated to be related to visually stressful striped patterns [24]. In addition, both pattern glare and visual memory are regulated by γ-aminobutyric acid (GABA). It has been known that lower GABA is associated with impaired visual memory, while the effect of GABA on pattern glare is greater under binocular conditions than under monocular conditions [13, 25].

MDD patients have abnormal activation of the visual-related cortex. A previous functional neuroimaging study of the brain suggested alterations in activity in visual association areas, including the occipital lobe, lingual gyrus, and fusiform gyrus, in those with MDD [26, 27]. Emerging evidence has indicated altered brain asymmetry in depressed individuals; thus, the lateralized and efficient visual processing system is disrupted when processing visual information [28]. On the one hand, it has been revealed that short-term visual memory depends on coding and activity in the visual cortex [29]. Impaired visual working memory in individuals with MDD has been found to be associated with alterations in the prefrontal cortex and amygdala and in visual cortex activation [26]. Reductions in hippocampal volume have been the most replicated findings and demonstrate that the hippocampus is associated with visual memory impairment in individuals with MDD [27, 29]. On the other hand, MDD is caused by a weakening of excitatory synapses in multiple brain regions [30]. Preclinical studies have indicated that adult GABA-dependent neurogenesis in the hippocampus is correlated with memory acquisition [31]. Reductions in inhibitory GABA levels have been observed in vision-related cortices in patients with MDD [32, 33]. Song et al. demonstrated that reductions in occipital GABA were related to impaired visual perception in acute depressive episodes [20].

Furthermore, colored tints or filters have been reported to reduce perceptual distortions, headaches, and discomfort from striped patterns and improve reading in dyslexia [14, 34]. Nevertheless, it is unclear whether visual memory is related to pattern glare.

Therefore, we hypothesized that MDD patients have abnormal visual memory and pattern glare scores and that visual memory is associated with pattern glare scores in MDD. To test this hypothesis, we analyzed the differences in visual memory and pattern glare levels between patients having MDD and healthy controls (HCs). We also analyzed the correlation between pattern glare and visual memory in attempt to identify the underlying mechanism of visual memory impairment.

Methods

Participants

The study recruited 62 inpatients with MDD (38 women, mean age 25.77 years) from the Mental Health Centre of West China Hospital, Sichuan University, between September, 2019 and December, 2020. All patients were Han Chinese between the ages of 18 and 60 years. The MDD participants were diagnosed based on the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) and met the criteria for a depressive episode in the Structured Clinical Interview for DSM-V (SCID). MDD patients had never received anti-depression treatment or stopped treatment for at least 3 months or have taken drugs for no more than 3 days at the time of recruitment. Patients were excluded if they 1)　had any serious physical diseases, especially nervous system diseases; 2) had a comorbid axis I disorder; 3) could not complete the test because of problems such as eye disease, impaired vision, or color acuity; 4) had received electroconvulsive therapy; or 5) were pregnant or lactating. The 17-item Hamilton Depression Rating Scale (HAMD) was used to measure the severity of depressive symptoms.

Forty-nine age-, sex- and education level-matched HCs (32 women, mean age: 26.45 years) who had no axis I mental disorder according to SCID-NP were recruited. Other inclusion and exclusion criteria were consistent with the MDD group.

All participants were informed about the details of the study, and written consent was obtained. The Ethics Committee of West China Hospital of Sichuan University approved this study.

Visual memory tests

Visual memory was assessed with the Pattern Recognition Memory (PRM) [35] test from the Cambridge Neuropsychological Test Automated Battery (CANTAB) assessment and the Brief Visual Memory Test-Revised (BVMT-R) from the Wechsler Adult Intelligence Scale-revised China (WAIS-RC) [36].

The PRM task consisted of two phases. At first, the participants were presented 12 colored shapes, one at a time, followed by pairs of shapes, one new and the other previously viewed. The participants had to select the previously viewed shape from each pair. After that, another 12 new shapes were presented in turn, and the participants were required to identify them after 20 min. Outcome data included percentage of correct responses in the immediate (PRM-PCi) and delayed (PRM-PCd) tests and the mean correct latency to responses in the immediate (MCLi) and delayed (MCLd) tests.

The BVMT-R is a measure of visuospatial short-term memory and learning. The participants needed to memorize six geometrical figures and their precise shapes and locations during the 10-s presentation. In addition, they needed to draw the memorized figures in the right location immediately afterwards, but the time they spent on drawing was not limited. Based on the accuracy of the shape (1 point) and location (1 point) of the figure, a score from 0 to 2 points for each figure was recorded. The procedure was repeated three times, and the total recall score consisted of the sum of the individual scores from the three trials. Outcome measures included the scores of the three tests and the total score: BVMT-R1, BVMT-R2, BVMT-R3, and BVMT-Rt.

With the exception of MCLi and MCLd, higher scores of the indicators indicated better visual memory performance.

Pattern glare test

Before the pattern glare test, the individuals were tested for visual acuity and color vision with the Snellen visual acuity chart. Individuals with abnormal visual acuity and color vision were excluded from this study. The present study employed the same pattern glare test as our previous investigation [22].

There were three types of pattern glare stimulation that differed in terms of their spatial frequency (SF). The three separate SFs in order of viewing included a low-SF pattern of 0.3 cycles per degree (cpd), a mid-SF pattern of 2.3 cpd and a high-SF pattern of 9.4 cpd. The low-SF pattern served as a control and at the same time ensured that the participants provided accurate responses. The mid-SF pattern was the main test, which was designed to elicit maximum visual discomfort. The high-SF pattern served as another control and was expected to generate fewer distortions than the mid-SF pattern. Viewing distance was approximately 40 cm[15]. Ambient light was sufficient to allow participants to view the printed glare tests clearly. For every presentation, the participants were allowed to concentrate on a small fixation dot in the middle of the picture for 5 s. They were asked to report which of the following 15 experiences were perceived: colors, including red, green, blue and yellow; bending, blurring or flickering of lines; shadowy shapes among the lines; fading; pain; nausea; dizziness; unease; discomforts; and other. The number of these perceived experiences reported was summed to provide a pattern glare score of each pattern [37]. The mid-high SF difference variable was obtained by subtracting the mid-SF score from the high-SF score and was also included in the analysis [38]. Participants with higher pattern glare scores were supposed to have more severe pattern glare [13].

Statistical analysis

Group comparisons for demographic, visual memory, and pattern glare were examined between MDD patients and HCs. The independent samples t-test was used for continuous variables (age, education year, visual memory, and pattern glare), and the χ2 test of independence for categorical variables (sex). Data were expressed as the mean and standard deviation (SD) for continuous variables. Partial correlation analysis was utilized to analyze the correlations between visual memory and pattern glare separately in MDD patients and HCs, and all participants; and age, sex, and education year were used as covariates. The false discovery rate (FDR) was controlled in multiple tests, and adjusted p value that less than 0.05 was deemed to be statistically significant [39]. Effect size (Cohen d) was reported for continuous variables. Statistical analyses were performed using SPSS 26.0 (IBM, Armonk, NY, USA).

Results

Demographic characteristics

No significant differences were observed between the MDD patients and HCs in terms of age, gender or education years (all p > 0.05). The HAMD score of MDD patients was 20.24 ± 3.778 (Table 1).

Table 1 Differences in demographic characteristics between the MDD patients and HCs
Full size table

Differences in visual memory between MDD patients and HCs

MDD patients had significantly lower PRM-PCi (t = 7.535, Cohen’s d = 0.601, p = 0.014), BVMT-R1 (t = 5.703, Cohen’s d = 0.476, p = 0.025), BVMT-R2 (t = 7.512, Cohen’s d = 0.532, p = 0.014), BVMT-R3 (t = 7.647, Cohen’s d = 0.570, p = 0.014), and BVMT-Rt (t = 10.079, Cohen’s d =  = 0.632, p = 0.014) scores and higher PRM-MCLd scores (t = -6.058, Cohen’s d = 0.482, p = 0.024) than HCs. All p values were corrected by FDR. No significant differences were found in PRM-MCLi and PRM-PCd scores between MDD patients and HCs (Table 2).

Table 2 Comparison on visual memory between MDD patients and HCs
Full size table

Differences in pattern glare between MDD patients and HCs

MDD patients had higher scores than HCs when viewing the mid-SF grating (t = 6.01, Cohen’s d = 1.15, p < 0.001) and high-SF grating (t = 2.97, Cohen’s d = 0.56, p = 0.006) and with the mid-high difference scores (t = 2.70, Cohen’s d = 0.52, p = 0.010). All p values were corrected by FDR (sTable 1, Fig. 1).

Fig. 1
figure 1

Comparisons of pattern glare scores between MDD patients and HCs. p*, corrected by FDR correction. Abbreviations: MDD, major depressive disorder; HCs, healthy controls; BVMT, Brief Visual Memory Test-Revised

Full size image

Correlations between pattern glare and visual memory

In the present study, mid-high difference scores were negatively correlated with BVMT-R2 scores (p = 0.032, r = -0.317) in HCs after controlling for age, sex, and years of education; but no association was observed in MDD patients. In addition, Mid-SF scores were positively correlated with PRM-MCLd scores (p = 0.010, r = 0.246) in all participants ( sTable 2, Fig. 2).

Fig. 2
figure 2

Correlations between pattern glare and visual memory. A Correlation between mid-SF and PRM-MCLd scores in all participants. B Correlation between mid-high SF differences and BVMT-R2 scores in healthy controls

Full size image

Discussion

In this case–control study involving 62 MDD patients and 49 well-matched HCs, we analyzed the difference in pattern glare and visual memory between MDD patients and HCs. Our results suggested that MDD patients have impaired visual memory and elevated pattern glare, and elevated pattern glare is associated with visual memory impairment in HCs.

Visual memory impairment in MDD patients

In agreement with previous studies, MDD patients in the present study demonstrated deficits in visual memory [7, 40, 41]. Consistent with our previous work, impairments in delayed visual spatial memory were identified in unmedicated MDD patients [42]. Both visuospatial learning and memory were impaired in young adult outpatients with MDD [43]. MDD patients without anxiety have better cognitive function than those with anxiety measured by the BVMT-R [36]. A previous study confirmed significant improvements in visual memory after treatment [40]. In line with an article demonstrating that processing speed in MDD patients is slower than that in HCs, we also found significant differences in the PRM-MCLd (correct latency to responses) between MDD patients and HCs [44].

Studies on the structure and function of the brain have revealed some possible explanations for the relationship between visual memory impairments and depression. An accumulating body of studies has reported that MDD patients have volumetric alterations in the hippocampus that are closely related to visual memory impairments [8, 45]. Decreased levels of GABA in the occipital lobe were related to impaired visual perception in acute depressive episodes [20]. The lateralized and efficient visual processing system was disrupted when processing visual information by deficits in brain asymmetry [28].

Elevated pattern glare in MDD patients

Our results showed that MDD patients have an elevated pattern glare. In agreement with our previous work, the patients with MDD scored higher in the mid and high SFs than HCs [22]. Similar findings were reported by Golomb et al., who applied a perceptual task designed to be similar to pattern glare models. They found that MDD patients had enhanced motor perception for typical inhibitory stimuli compared with the HCs, indicating that MDD patients exhibited decreased spatial suppression [46]. This result was replicated by Song et al. who demonstrated deficits in visual surround motion suppression in acute MDD patients [20]. Various findings have shown that the balance of excitation and inhibition mediates visual spatial suppression [47, 48]. Spatial inhibition occurs when the contrast of visual information is high, which reflects the antagonism of central and peripheral nerves in the middle temporal visual area [49].

The reduction of GABA in the visual cortex is thought to result in an activated visual cortex [46]. GABA reductions were found in the occipital cortex of untreated MDD patients in remission, the anterior cingulate cortex of young MDD patients, and the anterior lateral / medial prefrontal lobe of MDD patients [50,51,52]. Decreased GABA in the visual cortex of individuals with MDD may lead to an enhancement of visual cortex excitability.

Relationship of pattern glare and visual memory

The present study indicated that pattern glare has a negative effect on short-term visual memory in healthy individuals. Pattern glare is visual perceptual distortions and / or physical discomforts. One with elevated pattern glare will experience visual perceptual or physical discomfort when viewing repetitive stripes [13]. Distractions when representing information can damage storage mediated by the visual cortex and lead to disruptions in working memory [53]. Therefore, individuals with elevated pattern glare may have an accompanying visual memory impairment in conditions where the brain’s essential function is coordinated and stable.

Decreased GABA and hyperexcitability in the visual cortex seem to partly explain the relationship between elevated pattern glare and impaired visual memory in those with MDD [25]. Nevertheless, no significant association was observed between visual memory and pattern glare in MDD patients in the present study. Such results may be due to the limited sample size and heterogeneity of MDD.

Symptoms associated with a high level of pattern glare can be relieved by color filters or colored glasses [14]. We found that high-level pattern glare may be associated with visual memory impairment in HCs. Colored covers can be considered in some special conditions, such as the need for improved memory of visual information containing repetitive stripes [54]. Further research is needed to verify this recommendation for depression.

Despite the findings aforementioned, the present study has several limitations. First, we had a relatively small sample size, which in part resulted in no significant relationship between pattern glare and visual memory in MDD patients. Second, also because of the small sample size, we were unable to further divide our participants into subgroups for more specified analysis. In a sense, however, we have tried to minimize the medication impact on both visual memory and pattern glare by choosing currently unmedicated MDD patients although they had been on medication before. In the future, we may conduct similar studies on the first episode, drug-naive MDD patients and those having recurrent depressive disorders to minimize bias. Third, we did not explore the exact mechanism of GABA and neuroimaging. Future researchers may take the effect of brain structure and function and GABA levels in the visual-related cortex into consideration and improve the statistical efficiency of analyzing pattern glare levels and the influencing factors of visual memory. Fourth, the present study failed to provide direct evidence for improving visual memory since this was an association analysis in a case–control study. Longitudinal follow-up study is needed to verify the diagnosis of unipolar depression and to observe the changes in pattern glare and visual memory with the improvement of depressive symptoms. Finally, we did not take any interventions in the present study which is still preliminary. Measures are to be taken to alleviate pattern glare after further research on this issue, which is expected to make possible the direct observation of the effect of pattern glare on visual memory.

Conclusions

Our study on the relationship between pattern glare and visual memory in patients with MDD showed that MDD patients had elevated levels of pattern glare and visual memory impairments. Moreover, visual memory was negatively associated with pattern glare in healthy controls. The underlying pathological mechanism of the association between high level of pattern glare and visual memory processing deserves further study.

Availability of data and materials

The datasets generated and analyzed during the present study are not publicly available due to no permission from the ethics committee, but are available from the corresponding author on reasonable request.

Abbreviations

MDD:

Major depressive disorder

GABA:

γ-Aminobutyric acid

HCs:

Healthy controls

HAMD:

Hamilton Depression Rating Scale

PRM:

Pattern Recognition Memory

CANTAB:

Cambridge Neuropsychological Test Automated Battery

BVMT-R:

Brief Visual Memory Test-Revised

WAIS-RC:

Wechsler Adult Intelligence Scale-revised China

References

  1. Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–312.

    Article  PubMed  Google Scholar 

  2. Arbanas G: Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Codas 2015, 25.

  3. Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord. 2012;140(2):113–24.

    Article  PubMed  Google Scholar 

  4. Chen C, Jiang WH, Wang W, Ma XC, Li Y, Wu J, Hashimoto K, Gao CG. Impaired visual, working, and verbal memory in first-episode, drug-naive patients with major depressive disorder in a Chinese population. PLoS One. 2018;13(4):e0196023.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Dam VH, Stenbæk DS, Köhler-Forsberg K, Ip C, Ozenne B, Sahakian BJ, Knudsen GM, Jørgensen MB, Frokjaer VG. Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study. Psychol Med. 2020;51(14):2347–56.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hinkelmann K, Moritz S, Botzenhardt J, Riedesel K, Wiedemann K, Kellner M, Otte C. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry. 2009;66(9):879–85.

    Article  CAS  PubMed  Google Scholar 

  7. Travis S, Coupland NJ, Silversone PH, Huang Y, Fujiwara E, Carter R, Seres P, Malykhin NV. Dentate gyrus volume and memory performance in major depressive disorder. J Affect Disord. 2015;172:159–64.

    Article  PubMed  Google Scholar 

  8. Turner AD, Furey ML, Drevets WC, Zarate C Jr, Nugent AC. Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls. Neuropsychologia. 2012;50(9):2348–55.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Baune BT, Air T. Clinical, Functional, and Biological Correlates of Cognitive Dimensions in Major Depressive Disorder - Rationale, Design, and Characteristics of the Cognitive Function and Mood Study (CoFaM-Study). Front Psychiatry. 2016;7:150.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Maeshima H, Baba H, Nakano Y, Satomura E, Namekawa Y, Takebayashi N, Suzuki T, Mimura M, Arai H. Residual memory dysfunction in recurrent major depressive disorder–a longitudinal study from Juntendo University Mood Disorder Project. J Affect Disord. 2012;143(1–3):84–8.

    Article  PubMed  Google Scholar 

  11. IsHak WW, James DM, Mirocha J, Youssef H, Tobia G, Pi S, Collison KL, Cohen RM. Patient-reported functioning in major depressive disorder. Ther Adv Chronic Dis. 2016;7(3):160–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kupferberg A, Bicks L, Hasler G. Social functioning in major depressive disorder. Neurosci Biobehav Rev. 2016;69:313–32.

    Article  PubMed  Google Scholar 

  13. Evans BJ, Stevenson SJ. The Pattern Glare Test: a review and determination of normative values. Ophthalmic Physiol Opt. 2008;28(4):295–309.

    Article  CAS  PubMed  Google Scholar 

  14. Huang J, Zong X, Wilkins A, Jenkins B, Bozoki A, Cao Y. fMRI evidence that precision ophthalmic tints reduce cortical hyperactivation in migraine. Cephalalgia. 2011;31(8):925–36.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Beasley IG, Davies LN. Susceptibility to pattern glare following stroke. J Neurol. 2012;259(9):1832–9.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ludlow AK, Wilkins AJ, Heaton P. The Effect of Coloured Overlays on Reading Ability in Children with Autism. J Autism Dev Disord. 2006;36(4):507–16.

    Article  PubMed  Google Scholar 

  17. Friberg TR, Bremer RW, Dickinsen M. Diminished perception of light as a symptom of depression: further studies. J Affect Disord. 2008;108(3):235–40.

    Article  PubMed  Google Scholar 

  18. Anagnostou E, Vikelis M, Tzavellas E, Ghika A, Kouzi I, Evdokimidis I, Kararizou E. Photophobia in primary headaches, in essential blepharospasm and in major depression. Int J Neurosci. 2017;127(8):673–9.

    Article  PubMed  Google Scholar 

  19. Chang Y, Xu J, Shi N, Pang X, Zhang B, Cai Z. Dysfunction of preattentive visual information processing among patients with major depressive disorder. Biol Psychiatry. 2011;69(8):742–7.

    Article  PubMed  Google Scholar 

  20. Song XM, Hu XW, Li Z, Gao Y, Ju X, Liu DY, Wang QN, Xue C, Cai YC, Bai R, et al. Reduction of higher-order occipital GABA and impaired visual perception in acute major depressive disorder. Mol Psychiatry. 2021;26(11):6747–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Salmela V, Socada L, Soderholm J, Heikkila R, Lahti J, Ekelund J, Isometsa E. Reduced visual contrast suppression during major depressive episodes. J Psychiatry Neurosci. 2021;46(2):E222–31.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Qi X, Fan H, Yang X, Chen Y, Deng W, Guo W, Wang Q, Chen E, Li T, Ma X. High level of pattern glare in major depressive disorder. BMC Psychiatry. 2019;19(1):415.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jie H, Cooper TG, Satana B, Kaufman DI, Yue C. Visual distortion provoked by a stimulus in migraine associated with hyperneuronal activity. Headache. 2003;43(6):664–71.

    Article  Google Scholar 

  24. Huang J, Zhu DC. Visually stressful striped patterns alter human visual cortical functional connectivity. Hum Brain Mapp. 2017;38(11):5474–84.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Arnold W, Ian NS, Anne T, Christopher M, Della SS, Andrew T, Kim A, Margaret B, Sydney S. A neurological basis for visual discomfort. Brain. 1984;4:989–1017.

    Google Scholar 

  26. Le TM, Borghi JA, Kujawa AJ, Klein DN, Leung HC. Alterations in visual cortical activation and connectivity with prefrontal cortex during working memory updating in major depressive disorder. Neuroimage Clin. 2017;14:43–53.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Zhong X, Shi H, Ming Q, Dong D, Zhang X, Zeng LL, Yao S. Whole-brain resting-state functional connectivity identified major depressive disorder: a multivariate pattern analysis in two independent samples. J Affect Disord. 2017;218:346–52.

    Article  PubMed  Google Scholar 

  28. Ding YD, Yang R, Yan CG, Chen X, Bai TJ, Bo QJ, Chen GM, Chen NX, Chen TL, Chen W, et al. Disrupted hemispheric connectivity specialization in patients with major depressive disorder: Evidence from the REST-meta-MDD Project. J Affect Disord. 2021;284:217–28.

    Article  PubMed  Google Scholar 

  29. Sneve MH, Alnaes D, Endestad T, Greenlee MW, Magnussen S. Visual short-term memory: activity supporting encoding and maintenance in retinotopic visual cortex. Neuroimage. 2012;63(1):166–78.

    Article  PubMed  Google Scholar 

  30. Thompson SM, Kallarackal AJ, Kvarta MD, Van Dyke AM, LeGates TA, Cai X. An excitatory synapse hypothesis of depression. Trends Neurosci. 2015;38(5):279–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Sibbe M, Kulik A. GABAergic Regulation of Adult Hippocampal Neurogenesis. Mol Neurobiol. 2017;54(7):5497–510.

    Article  CAS  PubMed  Google Scholar 

  32. Ironside M, Moser AD, Holsen LM, Zuo CS, Du F, Perlo S, Richards CE, Duda JM, Chen X, Nickerson LD et al. Reductions in rostral anterior cingulate GABA are associated with stress circuitry in females with major depression: a multimodal imaging investigation. Neuropsychopharmacol. 2021.

  33. Truong V, Cheng PZ, Lee HC, Lane TJ, Hsu TY, Duncan NW. Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: an mrs study and meta-analysis. Psychiatry Res Neuroimaging. 2021;308:111238.

    Article  PubMed  Google Scholar 

  34. Newman Wright B, Wilkins AJ, Zoukos Y. Spectral filters can improve reading and visual search in patients with multiple sclerosis. J Neurol. 2007;254(12):1729–35.

    Article  CAS  PubMed  Google Scholar 

  35. Campos-Magdaleno M, Leiva D, Pereiro AX, Lojo-Seoane C, Mallo SC, Facal D, Juncos-Rabadan O. Changes in visual memory in mild cognitive impairment: a longitudinal study with CANTAB. Psychol Med. 2020;51(14):2465–75.

    Article  PubMed  Google Scholar 

  36. Duan Y, Wei J, Geng W, Jiang J, Zhao X, Li T, Jiang Y, Shi L, Cao J, Zhu G, et al. Research on Cognitive Function in Anxious Depression Patients in China. J Affect Disord. 2021;280(Pt A):121–6.

    Article  PubMed  Google Scholar 

  37. Allen PM, Hussain A, Usherwood C, Wilkins AJ. Pattern-related visual stress, chromaticity, and accommodation. Invest Ophthalmol Vis Sci. 2010;51(12):6843–9.

    Article  PubMed  Google Scholar 

  38. Han D, Wegrzyn J, Bi H, Wei R, Zhang B, Li X. Practice makes the deficiency of global motion detection in people with pattern-related visual stress more apparent. PLoS One. 2018;13(2):e0193215.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Methodol. 1995;57(1):289–300.

    Google Scholar 

  40. Hammar Å, Schmid M. Visual Memory Performance in Patients with Major Depression: A 9-Month Follow-Up. Appl Neuropsychol Adult. 2013;20(3):192–6.

    Article  PubMed  Google Scholar 

  41. Teng Z, Wang L, Li S, Tan Y, Qiu Y, Wu C, Jin K, Chen J, Huang J, Tang H, et al. Low BDNF levels in serum are associated with cognitive impairments in medication-naive patients with current depressive episode in BD II and MDD. J Affect Disord. 2021;293:90–6.

    Article  CAS  PubMed  Google Scholar 

  42. Liu Y, Yang X, Zhao L, Zhang J, Li T, Ma X. Increased miR-132 level is associated with visual memory dysfunction in patients with depression. Neuropsychiatr Dis Treat. 2016;12:2905–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry. 2018;182(5):214.

    Google Scholar 

  44. Albert KM, Potter GG, McQuoid DR, Taylor WD. Cognitive performance in antidepressant-free recurrent major depressive disorder. Depress Anxiety. 2018;35(8):694–9.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kaymak SU, Demir B, Şentürk S, Tatar I, Aldur MM, Uluğ B. Hippocampus, glucocorticoids and neurocognitive functions in patients with first-episode major depressive disorders. Eur Arch Psychiatry Clin Neurosci. 2009;260(3):217–23.

    Article  PubMed  Google Scholar 

  46. Golomb JD, McDavitt JR, Ruf BM, Chen JI, Saricicek A, Maloney KH, Hu J, Chun MM, Bhagwagar Z. Enhanced visual motion perception in major depressive disorder. J Neurosci. 2009;29(28):9072–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ozeki H, Finn IM, Schaffer ES, Miller KD, Ferster D. Inhibitory stabilization of the cortical network underlies visual surround suppression. Neuron. 2009;62(4):578–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Sato TK, Haider B, Häusser M, Carandini M. An excitatory basis for divisive normalization in visual cortex. Nat Neurosci. 2016;19(4):568–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Pack CC, Hunter JN, Born RT. Contrast dependence of suppressive influences in cortical area MT of alert macaque. J Neurophysiol. 2005;93(3):1809–15.

    Article  PubMed  Google Scholar 

  50. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar participants. Biol Psychiatry. 2007;61(6):806–12.

    Article  CAS  PubMed  Google Scholar 

  51. Gabbay V, Bradley KA, Mao X, Ostrover R, Kang G, Shungu DC. Anterior cingulate cortex gamma-aminobutyric acid deficits in youth with depression. Transl Psychiatry. 2017;7(8):e1216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry. 2004;61(7):705–13.

    Article  CAS  PubMed  Google Scholar 

  53. Hallenbeck GE, Sprague TC, Rahmati M, Sreenivasan KK, Curtis CE. Working memory representations in visual cortex mediate distraction effects. Nat Commun. 2021;12(1):4714.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Monger LJ, Wilkins AJ, Allen PM. Pattern glare: the effects of contrast and color. Front Psychol. 2015;6:1651.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the participation of the study participants.

Statement

All methods including human-related experiments were carried out in accordance with relevant guidelines and regulations.

Funding

This study was supported by the Key Research and Development Program of the Science and Technology Department of Sichuan Province (No. 22ZDYF1531, No. 22ZDYF1696), the Program of Chengdu Science and Technology (No. 2021-YF05-00272-SN), the National Natural Science Foundation of China (No. 82001432), the China Postdoctoral Science Foundation (No. 2020TQ0213, No. 2020M683319), the Open Project Program of the National Laboratory of Pattern Recognition (No. 202000034), and the West China Hospital Postdoctoral Science Foundation (No. 2020HXBH104).

Author information

Author notes

  1. Min Wang and Xiongwei Qi contributed equally to this work.

Authors and Affiliations

  1. Psychiatric Laboratory and Mental Health Center, West China Hospital of Sichuan University, Chengdu, China

    Min Wang, Xiao Yang, Huanhuan Fan, Yikai Dou, Wanjun Guo, Qiang Wang, Tao Li & Xiaohong Ma

  2. Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China

    Min Wang, Xiao Yang, Huanhuan Fan, Yikai Dou, Wanjun Guo, Qiang Wang, Tao Li & Xiaohong Ma

  3. Yibin No.4 People’s Hospital, Yibin, China

    Xiongwei Qi

  4. Department of Psychiatry, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong

    Eric Chen

Authors
  1. Min Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiongwei Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huanhuan Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yikai Dou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wanjun Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qiang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eric Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiaohong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XHM, XWQ, XY, and MW were involved in the design of this study and contributed to the writing of the manuscript. WM was responsible for data analysis and interpretation. MW and XWQ wrote the manuscript. XHM, HHF, YKD, QW, WJG, EC, TL, and XWQ screened for eligible participants and were in charge of clinical information and statistics. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Xiaohong Ma.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the ethics committee of West China Hospital of Sichuan University. All participants provided written informed consent.

Consent for publication

Not applicable.

Competing interests

All authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: sTable 1.

Differences in pattern glare between MDD patients and HCs. sTable 2. Correlations between visual memory and pattern glare scores.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, M., Qi, X., Yang, X. et al. The pattern glare and visual memory are disrupted in patients with major depressive disorder. BMC Psychiatry 22, 518 (2022). https://doi.org/10.1186/s12888-022-04167-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-022-04167-9

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us